🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Mark your calendars! Join us in Palermo October 17-19, 2024, for the XXI NIBIT Meeting. Connect with leading minds, share insights, and explore new horizons in cancer immunology and immunotherapy. Don't miss out! #NIBIT2024

Fantastic #CIMT2024 Cellular Therapies session on latest developments in CAR-T #immunotherapy (Claudia Rössig @wu_muenster Uniklinik Münster) engineering NK therapy (Rafet MD Anderson Cancer Center) and rewiring microbiota to enhance CAR-T into solid tumors (Tal Danino Columbia University) 🧬🧫🦠

Great to have Mat. in the house! #CIMT2024 Thank you for your continued support of the CIMT Annual Meeting.

#CIMT2024 Session Focus on #Africa highlighting the fantastic effort by @NCIGopal NCI Center for Global Health National Cancer Institute and Dr Cathy Nyongesa Texas Cancer Centre in delivering affordable cost effective cancer treatment and #Immunotherapy-based Healthcare #care #equality #clinicaltrial 💊🔬👏👏

Last session #CIMT2024: fascinating impact of #immunometabolism in reshaping tumor #microenvionment and enhancing #therapy of tissue-resident memory T-cells (Miguel Reina-Campos La Jolla Institute) #TAM macrophages (Jennifer Guerriero, PhD Dana-Farber) and CD8+ reprogramming (Jin Chen UChicago Medicine)

Recruitment! We are looking for a candidate for the lab (postdoc or scientist) with experience in yeast and/or phage display to work on some cool bioengineering projects for immunotherapy development! Please reach out if interested! Science friends, please retweet!

Are you a PhD student or postdoc with a research focus in cellular immunotherapies? Apply by June 14 to present your work, connect with peers and scientific leaders in an extraordinary retreat setting in Portugal. cimt.eu/summer-school

Register by July 15, and save with early-bird discounts for #CICON24, presented by CRI and ENCI, in conjunction with ENCI partner organizations, Cancer Immunotherapy, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held from September 8-11, 2024: bit.ly/49Bceq8

Thank you The Binder Lab and Marieke Essers HI-STEM - Cancer and Stem Cells in Heidelberg for organizing this fantastic #interferon Symposium 👏🏻👏🏻 great opportunity to present our work and build up new connections, I learned a lot! ✍️🧬🔬

Register before July 15 to get the early-bird discount 🐦 #CICON24

Join us in beautiful Lisbon to explore cellular therapies for solid tumors. Academic researchers attend for free. Don’t miss this unique opportunity to engage with leading experts and pioneers in the field. cimt.eu/cancer-cell-th…

Interested in the evolution of how we share and curate our science? For those coming to CICON24, check out Beiyun C Liu and this poster. For those not there, try this out, participate, enjoy helping science and your colleagues move forward: solvingfor.org/campaigns-data…

The Eighth International Cancer Immunotherapy Conference kicks off this morning! Joining the Cancer Research Institute and ENCI in National Harbor, MD today? Share your own photos and content from the conference, using the hashtag #CICON24 to be reposted!

Discover the groundbreaking research and collaboration that's driving the future of cancer immunotherapy, in our daily recap blog from the first day of #CICON24, presented by CRI and ENCI, in conjunction with Cancer Immunotherapy, EATI, NIBIT, and GÉTICA: bit.ly/47l3TXz

To young researchers at #CICON24 who are navigating their futures in the field of cancer research, Memorial Sloan Kettering Cancer Center's Dr. Dana Pe'er emphasizes, "You need to follow your passion, because passion drives ideas. Passion drives innovation." #CancerResearch #Immunotherapy

During an exclusive interview from the second day of #CICON24, Dr. Andrew Koh from UT Southwestern Medical Center describes what excites him most about the current state of cancer immunotherapy! #Immunotherapy #CancerResearch

The fourth day of #CICON24 concluded the conference with a half-day of intense focus on the future of cancer care and treatment! Explore research shared during the event's ninth session, and more, in today's recap blog: bit.ly/4gizhKt #CancerResearch #CancerVaccines

CIMT Summer School is in full swing here at the beautiful Castelo de Palmela, Portugal with lectures, flash talks and posters on cellular cancer immunotherapies. A big thank you to our partner, the Champalimaud Foundation ChampalimaudF for their support in making this possible.

🌟 Thank you to @IRCM_MTP Alexandre Djiane for the warm invitation to visit your institute and showcase our work in #leukemia #microenvionment and #epigenetictherapy. Excited to share ideas and engage with such a vibrant scientific community and potential collaborations. Merci! 🇫🇷 💊👨‍🔬

Catch us on Bluesky: kimjintae.bsky.social